These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 16596499)

  • 21. Economic analysis of a randomized trial of biventricular pacing in Canada.
    Bentkover JD; Dorian P; Thibault B; Gardner M
    Pacing Clin Electrophysiol; 2007 Jan; 30(1):38-43. PubMed ID: 17241313
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiac-resynchronization therapy.
    Wilson JR
    N Engl J Med; 2010 Jan; 362(2):178; author reply 179. PubMed ID: 20077591
    [No Abstract]   [Full Text] [Related]  

  • 23. [From implantable cardioverter-defibrillator to cardiac resynchronization therapy with the use of epicardial left ventricular lead. The evolution of the treatment of post inflammatory heart failure--a case report].
    Gepner K; Sterliński M; Przybylski A; Maciag A; Kołsut P; Szwed H
    Kardiol Pol; 2006 Oct; 64(10):1113-7. PubMed ID: 17089244
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antitachycardia pacing for spontaneous rapid ventricular tachycardia in patients with prophylactic cardioverter-defibrillator therapy.
    Grimm W; Plachta E; Maisch B
    Pacing Clin Electrophysiol; 2006 Jul; 29(7):759-64. PubMed ID: 16884513
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Resynchronization therapy for heart insufficiency].
    Butter C
    Dtsch Med Wochenschr; 2006 Sep; 131(39):2153-7. PubMed ID: 16991031
    [No Abstract]   [Full Text] [Related]  

  • 26. Cardiac-resynchronization therapy.
    Carrigan TP; Sipahi I
    N Engl J Med; 2010 Jan; 362(2):177; author reply 179. PubMed ID: 20077590
    [No Abstract]   [Full Text] [Related]  

  • 27. Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials.
    Ghanbari H; Dalloul G; Hasan R; Daccarett M; Saba S; David S; Machado C
    Arch Intern Med; 2009 Sep; 169(16):1500-6. PubMed ID: 19752408
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiac resynchronization therapy for mild congestive heart failure.
    Technol Eval Cent Assess Program Exec Summ; 2010 Apr; 24(8):1-5. PubMed ID: 20575185
    [No Abstract]   [Full Text] [Related]  

  • 29. [Cardiac resynchronization therapy: are all questions answered?].
    Auricchio A
    Herzschrittmacherther Elektrophysiol; 2005 Mar; 16(1):1-2. PubMed ID: 15824869
    [No Abstract]   [Full Text] [Related]  

  • 30. Cardiac resynchronization therapy in patients with end-stage inotrope-dependent class IV heart failure.
    Herweg B; Ilercil A; Cutro R; Dewhurst R; Krishnan S; Weston M; Barold SS
    Am J Cardiol; 2007 Jul; 100(1):90-3. PubMed ID: 17599447
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multiple shocks after upgrade of an implantable cardioverter-defibrillator to a cardiac resynchronization therapy-defibrillator device.
    Francisco GM; Sharma S; Dougherty AH; Kantharia BK
    Cardiol J; 2009; 16(5):473-6. PubMed ID: 19753529
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Left ventricular endocardial pacing improves the clinical efficacy in a non-responder to cardiac resynchronization therapy: role of acute haemodynamic testing.
    Bracke FA; Houthuizen P; Rahel BM; van Gelder BM
    Europace; 2010 Jul; 12(7):1032-4. PubMed ID: 20200018
    [No Abstract]   [Full Text] [Related]  

  • 33. A novel cardiac MRI protocol to guide successful cardiac resynchronization therapy implantation.
    Duckett SG; Ginks M; Knowles BR; Chiribiri A; Ma YL; Razavi R; Schaeffter T; Carr-White G; Rinaldi CA; Rhode K
    Circ Heart Fail; 2010 Jul; 3(4):e18-21. PubMed ID: 20647480
    [No Abstract]   [Full Text] [Related]  

  • 34. Use of traditional and biventricular implantable cardiac devices for primary and secondary prevention of sudden death.
    Klein MH; Gold MR
    Cardiol Clin; 2008 Aug; 26(3):419-31, vi-vii. PubMed ID: 18538188
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [CRT. ICD. LVAS].
    Wakayama Y; Shiba N; Shirato K
    Nihon Rinsho; 2006 May; 64(5):818-20. PubMed ID: 16689358
    [No Abstract]   [Full Text] [Related]  

  • 36. Primary prevention of sudden cardiac death using implantable cardioverter defibrillators.
    Ding L; Hua W; Niu H; Chen K; Zhang S
    Europace; 2008 Sep; 10(9):1034-41. PubMed ID: 18559335
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patients with heart failure who require an implantable defibrillator should have cardiac resynchronisation routinely.
    Cleland JG; Tageldien A; Maarouf N; Hobson N
    Heart; 2008 Aug; 94(8):963-6. PubMed ID: 18625785
    [No Abstract]   [Full Text] [Related]  

  • 38. Relationship between New York Heart Association class change and ventricular tachyarrhythmia occurrence in patients treated with cardiac resynchronization plus defibrillator.
    Lepillier A; Piot O; Gerritse B; Copie X; Lavergne T; Paziaud O; Lascault G; Waintraub X; Otmani A; Le Heuzey JY
    Europace; 2009 Jan; 11(1):80-5. PubMed ID: 18952828
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pressure-volume loop analysis during implantation of biventricular pacemaker/cardiac resynchronization therapy device to optimize right and left ventricular pacing sites.
    Delnoy PP; Ottervanger JP; Luttikhuis HO; Vos DH; Elvan A; Ramdat Misier AR; Beukema WP; Steendijk P; van Hemel NM
    Eur Heart J; 2009 Apr; 30(7):797-804. PubMed ID: 19202156
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reducing mortality with device therapy in heart failure patients without ventricular arrhythmias.
    Chapa DW; Lee HJ; Kao CW; Friedmann E; Thomas SA; Anderson J; Bardy GH
    Am J Crit Care; 2008 Sep; 17(5):443-52; quiz 453. PubMed ID: 18776000
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.